Disease
5 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
AUG 18, 2026 · PHASE 3 TRIAL
ClinicalTrials.gov
Phase 3 trial with completed recruitment (n=23) examining surrogate immune endpoints in Alzheimer's disease; no results posted in this registry record.
AUG 17, 2026 · PHASE 1 TRIAL
ClinicalTrials.gov
This is a Phase 1 trial registration with no reported results; it is designed to evaluate safety, tolerability, and proof of mechanism in a small population, and cannot yet inform clinical practice.
AUG 13, 2026 · OBSERVATIONAL STUDY
ClinicalTrials.gov
This is a planned observational registry study with no results yet reported; it will characterize safety and disease progression in routine clinical practice but cannot yet inform clinical decisions.
AUG 6, 2026 · PHASE 3 TRIAL
ClinicalTrials.gov
This is a registry record of an ongoing Phase 3 trial with no results posted; the study is recruiting and outcomes have not yet been reported.
AUG 6, 2026 · PHASE 3 TRIAL
ClinicalTrials.gov
This is a clinical trial registry record for a Phase 3 study that is actively recruiting; no results are reported, making this a description of planned research rather than evidence of efficacy or safety.